UniProt ID | CEBPZ_HUMAN | |
---|---|---|
UniProt AC | Q03701 | |
Protein Name | CCAAT/enhancer-binding protein zeta | |
Gene Name | CEBPZ | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1054 | |
Subcellular Localization | Nucleus. | |
Protein Description | Stimulates transcription from the HSP70 promoter.. | |
Protein Sequence | MAAVKEPLEFHAKRPWRPEEAVEDPDEEDEDNTSEAENGFSLEEVLRLGGTKQDYLMLATLDENEEVIDGGKKGAIDDLQQGELEAFIQNLNLAKYTKASLVEEDEPAEKENSSKKEVKIPKINNKNTAESQRTSVNKVKNKNRPEPHSDENGSTTPKVKKDKQNIFEFFERQTLLLRPGGKWYDLEYSNEYSLKPQPQDVVSKYKTLAQKLYQHEINLFKSKTNSQKGASSTWMKAIVSSGTLGDRMAAMILLIQDDAVHTLQFVETLVNLVKKKGSKQQCLMALDTFKELLITDLLPDNRKLRIFSQRPFDKLEQLSSGNKDSRDRRLILWYFEHQLKHLVAEFVQVLETLSHDTLVTTKTRALTVAHELLCNKPEEEKALLVQVVNKLGDPQNRIATKASHLLETLLCKHPNMKGVVSGEVERLLFRSNISSKAQYYAICFLNQMALSHEESELANKLITVYFCFFRTCVKKKDVESKMLSALLTGVNRAYPYSQTGDDKVREQIDTLFKVLHIVNFNTSVQALMLLFQVMNSQQTISDRYYTALYRKMLDPGLMTCSKQAMFLNLVYKSLKADIVLRRVKAFVKRLLQVTCQQMPPFICGALYLVSEILKAKPGLRSQLDDHPESDDEENFIDANDDEDMEKFTDADKETEIVKKLETEETVPETDVETKKPEVASWVHFDNLKGGKQLNKYDPFSRNPLFCGAENTSLWELKKLSVHFHPSVALFAKTILQGNYIQYSGDPLQDFTLMRFLDRFVYRNPKPHKGKENTDSVVMQPKRKHFIKDIRHLPVNSKEFLAKEESQIPVDEVFFHRYYKKVAVKEKQKRDADEESIEDVDDEEFEELIDTFEDDNCFSSGKDDMDFAGNVKKRTKGAKDNTLDEDSEGSDDELGNLDDDEVSLGSMDDEEFAEVDEDGGTFMDVLDDESESVPELEVHSKVSTKKSKRKGTDDFDFAGSFQGPRKKKRNLNDSSLFVSAEEFGHLLDENMGSKFDNIGMNAMANKDNASLKQLRWEAERDDWLHNRDAKSIIKKKKHFKKKRIKTTQKTKKQRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Acetylation | ---MAAVKEPLEFHA ---CCCCCCCCCCCC | 49.22 | 25953088 | |
33 | Phosphorylation | DEEDEDNTSEAENGF CCCCCCCCCCHHCCC | 40.02 | 30266825 | |
34 | Phosphorylation | EEDEDNTSEAENGFS CCCCCCCCCHHCCCC | 40.85 | 30266825 | |
41 | Phosphorylation | SEAENGFSLEEVLRL CCHHCCCCHHHHHHC | 35.95 | 28176443 | |
52 | Acetylation | VLRLGGTKQDYLMLA HHHCCCCCCCEEEEE | 44.43 | 26051181 | |
72 | Acetylation | EEVIDGGKKGAIDDL CCEECCCCCCCHHHH | 54.27 | 26051181 | |
73 | Ubiquitination | EVIDGGKKGAIDDLQ CEECCCCCCCHHHHH | 57.77 | 29967540 | |
98 | Ubiquitination | LNLAKYTKASLVEED HCHHHHHHHHHHCCC | 32.65 | 21890473 | |
100 | Phosphorylation | LAKYTKASLVEEDEP HHHHHHHHHHCCCCH | 34.21 | 19691289 | |
110 | Acetylation | EEDEPAEKENSSKKE CCCCHHHCCCCCCCC | 65.39 | 26051181 | |
113 | Phosphorylation | EPAEKENSSKKEVKI CHHHCCCCCCCCEEC | 44.63 | 23186163 | |
114 | Phosphorylation | PAEKENSSKKEVKIP HHHCCCCCCCCEECC | 60.37 | - | |
126 | Acetylation | KIPKINNKNTAESQR ECCCCCCCCCHHHHH | 51.71 | 25953088 | |
131 | Phosphorylation | NNKNTAESQRTSVNK CCCCCHHHHHHHHHH | 23.62 | 25159151 | |
134 | Phosphorylation | NTAESQRTSVNKVKN CCHHHHHHHHHHHCC | 29.41 | 25627689 | |
135 | Phosphorylation | TAESQRTSVNKVKNK CHHHHHHHHHHHCCC | 26.36 | 25159151 | |
149 | Phosphorylation | KNRPEPHSDENGSTT CCCCCCCCCCCCCCC | 58.28 | 25159151 | |
154 | Phosphorylation | PHSDENGSTTPKVKK CCCCCCCCCCCCCCC | 40.46 | 24732914 | |
155 | Phosphorylation | HSDENGSTTPKVKKD CCCCCCCCCCCCCCC | 48.82 | 24732914 | |
156 | Phosphorylation | SDENGSTTPKVKKDK CCCCCCCCCCCCCCC | 23.86 | 25159151 | |
163 | 2-Hydroxyisobutyrylation | TPKVKKDKQNIFEFF CCCCCCCCCCHHHHH | 54.87 | - | |
174 | Phosphorylation | FEFFERQTLLLRPGG HHHHHHCEEEECCCC | 26.12 | 21406692 | |
184 | Phosphorylation | LRPGGKWYDLEYSNE ECCCCCEEECCCCCC | 17.71 | 18452278 | |
192 | Phosphorylation | DLEYSNEYSLKPQPQ ECCCCCCCCCCCCCH | 24.45 | 22817900 | |
193 | Phosphorylation | LEYSNEYSLKPQPQD CCCCCCCCCCCCCHH | 24.60 | 24719451 | |
195 | Acetylation | YSNEYSLKPQPQDVV CCCCCCCCCCCHHHH | 35.35 | 26051181 | |
203 | Phosphorylation | PQPQDVVSKYKTLAQ CCCHHHHHHHHHHHH | 30.07 | 18452278 | |
204 | Acetylation | QPQDVVSKYKTLAQK CCHHHHHHHHHHHHH | 38.87 | 26051181 | |
211 | Acetylation | KYKTLAQKLYQHEIN HHHHHHHHHHHHHHH | 43.48 | 25953088 | |
213 | Phosphorylation | KTLAQKLYQHEINLF HHHHHHHHHHHHHHH | 18.17 | 24719451 | |
221 | Acetylation | QHEINLFKSKTNSQK HHHHHHHHCCCCCCC | 54.96 | 26051181 | |
224 | Phosphorylation | INLFKSKTNSQKGAS HHHHHCCCCCCCCCC | 47.39 | 24719451 | |
231 | Phosphorylation | TNSQKGASSTWMKAI CCCCCCCCHHHHHHH | 36.65 | 20860994 | |
232 | Phosphorylation | NSQKGASSTWMKAIV CCCCCCCHHHHHHHH | 26.08 | 20860994 | |
233 | Phosphorylation | SQKGASSTWMKAIVS CCCCCCHHHHHHHHH | 27.38 | 29759185 | |
236 | Acetylation | GASSTWMKAIVSSGT CCCHHHHHHHHHCCC | 26.90 | 26051181 | |
240 | Phosphorylation | TWMKAIVSSGTLGDR HHHHHHHHCCCHHHH | 19.55 | 19691289 | |
241 | Phosphorylation | WMKAIVSSGTLGDRM HHHHHHHCCCHHHHH | 25.54 | 19691289 | |
243 | Phosphorylation | KAIVSSGTLGDRMAA HHHHHCCCHHHHHHH | 29.52 | 19691289 | |
279 | Acetylation | LVKKKGSKQQCLMAL HHHHCCCHHHHHHHH | 53.72 | 26051181 | |
314 | Acetylation | FSQRPFDKLEQLSSG ECCCCCHHHHHHHCC | 55.06 | 26051181 | |
314 | Ubiquitination | FSQRPFDKLEQLSSG ECCCCCHHHHHHHCC | 55.06 | 21906983 | |
319 | Phosphorylation | FDKLEQLSSGNKDSR CHHHHHHHCCCCCHH | 35.57 | 20068231 | |
320 | Phosphorylation | DKLEQLSSGNKDSRD HHHHHHHCCCCCHHH | 55.78 | 20068231 | |
323 | Acetylation | EQLSSGNKDSRDRRL HHHHCCCCCHHHHHH | 61.68 | 26051181 | |
376 | Acetylation | AHELLCNKPEEEKAL HHHHHCCCCHHHHHH | 53.46 | 26051181 | |
381 | Acetylation | CNKPEEEKALLVQVV CCCCHHHHHHHHHHH | 47.84 | 26051181 | |
390 | Acetylation | LLVQVVNKLGDPQNR HHHHHHHHHCCHHHH | 42.09 | 26051181 | |
390 | Ubiquitination | LLVQVVNKLGDPQNR HHHHHHHHHCCHHHH | 42.09 | - | |
397 | Methylation | KLGDPQNRIATKASH HHCCHHHHHHHHHHH | 18.05 | - | |
408 | Phosphorylation | KASHLLETLLCKHPN HHHHHHHHHHCCCCC | 25.62 | 29396449 | |
412 | Acetylation | LLETLLCKHPNMKGV HHHHHHCCCCCCCCC | 63.16 | 25953088 | |
412 | Ubiquitination | LLETLLCKHPNMKGV HHHHHHCCCCCCCCC | 63.16 | 29967540 | |
417 | Ubiquitination | LCKHPNMKGVVSGEV HCCCCCCCCCCCHHH | 56.01 | 29967540 | |
439 | Phosphorylation | NISSKAQYYAICFLN CCCCHHHHHHHHHHH | 10.34 | 26074081 | |
440 | Phosphorylation | ISSKAQYYAICFLNQ CCCHHHHHHHHHHHH | 4.20 | 26074081 | |
451 | Phosphorylation | FLNQMALSHEESELA HHHHHHCCHHHHHHH | 21.22 | 26074081 | |
455 | Phosphorylation | MALSHEESELANKLI HHCCHHHHHHHHHHH | 34.62 | 26074081 | |
463 | Phosphorylation | ELANKLITVYFCFFR HHHHHHHHHHHHHHH | 21.42 | 27251275 | |
465 | Phosphorylation | ANKLITVYFCFFRTC HHHHHHHHHHHHHHH | 5.98 | 27251275 | |
480 | Phosphorylation | VKKKDVESKMLSALL CCHHHHHHHHHHHHH | 24.18 | - | |
481 | Ubiquitination | KKKDVESKMLSALLT CHHHHHHHHHHHHHH | 30.29 | - | |
496 | Phosphorylation | GVNRAYPYSQTGDDK CCHHHCCCCCCCCHH | 10.75 | 16565220 | |
503 | 2-Hydroxyisobutyrylation | YSQTGDDKVREQIDT CCCCCCHHHHHHHHH | 48.18 | - | |
503 | Acetylation | YSQTGDDKVREQIDT CCCCCCHHHHHHHHH | 48.18 | 26051181 | |
503 | Ubiquitination | YSQTGDDKVREQIDT CCCCCCHHHHHHHHH | 48.18 | 24816145 | |
522 | Phosphorylation | LHIVNFNTSVQALML HHHCCCCHHHHHHHH | 26.57 | 24043423 | |
523 | Phosphorylation | HIVNFNTSVQALMLL HHCCCCHHHHHHHHH | 17.21 | 24043423 | |
536 | Phosphorylation | LLFQVMNSQQTISDR HHHHHHCCCCCCHHH | 12.93 | 24043423 | |
539 | Phosphorylation | QVMNSQQTISDRYYT HHHCCCCCCHHHHHH | 18.14 | 24043423 | |
541 | Phosphorylation | MNSQQTISDRYYTAL HCCCCCCHHHHHHHH | 21.30 | 24043423 | |
571 | Phosphorylation | AMFLNLVYKSLKADI HHHHHHHHHHHHHHH | 9.68 | 20068231 | |
572 | Ubiquitination | MFLNLVYKSLKADIV HHHHHHHHHHHHHHH | 41.66 | - | |
621 | Phosphorylation | KAKPGLRSQLDDHPE HCCCCHHHHCCCCCC | 39.89 | 23927012 | |
629 | Phosphorylation | QLDDHPESDDEENFI HCCCCCCCCCCCCCC | 55.61 | 23927012 | |
648 | Phosphorylation | DEDMEKFTDADKETE HHHHHHHCCCHHHHH | 41.15 | 23403867 | |
652 | 2-Hydroxyisobutyrylation | EKFTDADKETEIVKK HHHCCCHHHHHHHHH | 69.15 | - | |
654 | Phosphorylation | FTDADKETEIVKKLE HCCCHHHHHHHHHHC | 36.43 | 23403867 | |
669 | Phosphorylation | TEETVPETDVETKKP CCCCCCCCCCCCCCC | 39.00 | 30576142 | |
675 | Acetylation | ETDVETKKPEVASWV CCCCCCCCCCEEEEE | 54.55 | 26051181 | |
675 | Ubiquitination | ETDVETKKPEVASWV CCCCCCCCCCEEEEE | 54.55 | 29967540 | |
680 | Phosphorylation | TKKPEVASWVHFDNL CCCCCEEEEEEEECC | 34.50 | 28555341 | |
688 | Ubiquitination | WVHFDNLKGGKQLNK EEEEECCCCCCCCCC | 72.39 | 29967540 | |
695 | Acetylation | KGGKQLNKYDPFSRN CCCCCCCCCCCCCCC | 60.67 | 19608861 | |
717 | Acetylation | NTSLWELKKLSVHFH CCCHHHHHHHHCCCC | 39.90 | 26051181 | |
758 | Methylation | TLMRFLDRFVYRNPK HHHHHHHHHHHCCCC | 25.69 | - | |
770 | Ubiquitination | NPKPHKGKENTDSVV CCCCCCCCCCCCCEE | 53.23 | 24816145 | |
773 | Phosphorylation | PHKGKENTDSVVMQP CCCCCCCCCCEECCC | 30.64 | 29083192 | |
775 | Phosphorylation | KGKENTDSVVMQPKR CCCCCCCCEECCCCH | 17.99 | 21815630 | |
778 | Sulfoxidation | ENTDSVVMQPKRKHF CCCCCEECCCCHHHC | 5.45 | 21406390 | |
787 | Methylation | PKRKHFIKDIRHLPV CCHHHCCCCCCCCCC | 46.27 | - | |
787 | Ubiquitination | PKRKHFIKDIRHLPV CCHHHCCCCCCCCCC | 46.27 | 29967540 | |
797 | Ubiquitination | RHLPVNSKEFLAKEE CCCCCCCHHHHHHCH | 47.48 | 33845483 | |
802 | Acetylation | NSKEFLAKEESQIPV CCHHHHHHCHHCCCC | 65.25 | 26051181 | |
805 | Phosphorylation | EFLAKEESQIPVDEV HHHHHCHHCCCCCHH | 34.20 | 27067055 | |
835 | Phosphorylation | KRDADEESIEDVDDE CCCCCHHHCCCCCHH | 29.27 | 16565220 | |
850 | Phosphorylation | EFEELIDTFEDDNCF HHHHHHHHHCCCCCC | 23.17 | 20873877 | |
858 | Phosphorylation | FEDDNCFSSGKDDMD HCCCCCCCCCCCCCC | 40.14 | 20873877 | |
859 | Phosphorylation | EDDNCFSSGKDDMDF CCCCCCCCCCCCCCC | 29.61 | 20873877 | |
949 | Ubiquitination | STKKSKRKGTDDFDF CCCCCCCCCCCCCCC | 70.65 | 24816145 | |
951 | Phosphorylation | KKSKRKGTDDFDFAG CCCCCCCCCCCCCCC | 35.12 | 25159151 | |
959 | Phosphorylation | DDFDFAGSFQGPRKK CCCCCCCCCCCCCCC | 15.80 | 25159151 | |
973 | Phosphorylation | KKRNLNDSSLFVSAE CCCCCCCCCEEEEHH | 28.06 | 25159151 | |
974 | Phosphorylation | KRNLNDSSLFVSAEE CCCCCCCCEEEEHHH | 28.79 | 25159151 | |
978 | Phosphorylation | NDSSLFVSAEEFGHL CCCCEEEEHHHHHHH | 23.72 | 21712546 | |
992 | Phosphorylation | LLDENMGSKFDNIGM HHCCCCCCCCCHHHH | 21.27 | 24732914 | |
1005 | Acetylation | GMNAMANKDNASLKQ HHHHHCCCCCHHHHH | 42.70 | 26051181 | |
1011 | Methylation | NKDNASLKQLRWEAE CCCCHHHHHHHHHHH | 44.80 | - | |
1011 | Ubiquitination | NKDNASLKQLRWEAE CCCCHHHHHHHHHHH | 44.80 | 33845483 | |
1030 | Phosphorylation | LHNRDAKSIIKKKKH HCCCCHHHHHHHHHH | 31.13 | 24719451 | |
1051 | Ubiquitination | KTTQKTKKQRK---- CCCHHHHHHHC---- | 61.64 | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CEBPZ_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CEBPZ_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CEBPZ_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NFYB_HUMAN | NFYB | physical | 11306579 | |
P53_HUMAN | TP53 | physical | 12534345 | |
P73_HUMAN | TP73 | physical | 12534345 | |
EBP2_HUMAN | EBNA1BP2 | physical | 26344197 | |
PUM3_HUMAN | KIAA0020 | physical | 26344197 | |
NOLC1_HUMAN | NOLC1 | physical | 26344197 | |
NOP2_HUMAN | NOP2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-695, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629 AND SER-973, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629; SER-973 ANDSER-978, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34; SER-100 AND SER-241,AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231; SER-232 ANDTHR-233, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629 AND SER-835, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-835, AND MASSSPECTROMETRY. |